RankAlpha logo
Back to Rankings

OCS

OculisD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
OCS vs peer average
30/100
OCS vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 3 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Large-cap biotech benchmark for sector risk appetite and funding durability, but not a direct product or indication peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
OCS
Oculis
GILD
Gilead Sciences
Grade
D
C
Momentum
39
35
Value
41
64
Sentiment
41
61
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs GILD

OCS / GILD
Grade Position
Below peers
OCS vs. peer average (D vs. C)
30/100
Momentum
39
OCS
Value
41
GILD
Sentiment
41
GILD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OCS
1
GILD
GILD
C
60/100
-1
2
HROW
HROW
D
40/100
Even
3
AVTX
Avalo Therapeutics Inc Common
B
80/100
-2
4
TBPH
Theravance Biopharma Inc Common
C
60/100
-1
5
AMPH
Amphastar Pharmaceuticals Inc Common
D
40/100
Even
GILD is the first peer returned for this comparison set.